Join MC Julie McCrossin and keynote speaker - the world renowned clinician and researcher - Prof. Peter Hillmen from St James’s University Hospital Leeds, for a webinar that promises to be energetic and full of new information. People from all countries are welcome to join the webinar. You can register to attend the webinar or if you can't make it on the day, you can also register to receive a copy of the webinar recording. Everyone that attends will also have access to the webinar recording.
Prof Hillmen will be presenting on the treatment and research landscape for CLL stage B and C, and the UK FLAIR clinical trial. We will also have Ms Sharon Winton, Chief Executive Officer, Lymphoma Australia interviewed about support and services available for people with CLL and there will also be a panel discussion on what’s new in advocacy.
Registration: cc-dr.org/cll
Date: 21 October 2020 for 1 hour
Times:
9.00AM GMT: United Kingdom
7.00PM AEDT: Australia
8:00PM DST: New Zealand
Interested US members may find it more convenient to register for access to the webinar recording, given the inconvenient times - unless they are in Hawaii 
.
Brought to you by Lymphoma Australia and the Centre for Community-Driven Research (CC-DR). Incidentally, the survey of Australian CLL patients and their carers by CC-DR is still open: healthunlocked.com/cllsuppo...
seelel , thanks for your earlier post on this webinar: healthunlocked.com/cllsuppo....
Given the audience will primarily people diagnosed with CLL and their families, but with researchers and clinicians also welcomed, I've posted this notice unlocked.
Neil
